Mitra devices were used to capture 20 uL of whole blood (heparin or EDTA) followed by extraction with 5% deoxycholate (SDC) in ammonium bicarbonate, reduction/alkylation and digestion for 2 h with TPCK-trypsin. SDC was precipitated with acid and filtered. Peptides were adjusted to 80% MeCN and 1% TFA followed by purification of N-glycopeptides using Polyhydroxyethyl A spin tips. The flow though was saved for phosphopeptide enrichment, and N-glycopeptides were eluted with 0.1% TFA. Phosphopeptides were enriched using Ti-IMAC after adjusting 300 uL of flow through to 5% TFA and 0.25 M glycolic acid, and phosphopeptides were eluted with 1% NH4OH. The unenriched digest was analyzed by microflow LC and data-independent acquisition. The N-glycoenriched fraction was analyzed using an Evosep LC and Orbitral stepped-collision energy DDA-MS/MS or Orbitrap Astral DIA-MS/MS. Analyses used Spectronaut, GlycoDecipher and FragPipe glyco-N-DIA workflow with visualization in Skyline. Other details are given in the metadata file.
[doi:10.25345/C5WM1466D]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: n-glycoproteome ; mitra device ; sepsis ; DatasetType:Proteomics
|
Principal Investigators: (in alphabetical order) |
Matthew W. Foster, Duke University, USA |
| Submitting User: | mwfoster |
| Number of Files: | |
| Total Size: | |
| Spectra: | |
| Subscribers: | |
| Owner | Reanalyses | |
|---|---|---|
| Experimental Design | ||
|
Conditions:
|
||
|
Biological Replicates:
|
||
|
Technical Replicates:
|
||
| Identification Results | ||
|
Proteins (Human, Remapped):
|
||
|
Proteins (Reported):
|
||
|
Peptides:
|
||
|
Variant Peptides:
|
||
|
PSMs:
|
||
| Quantification Results | ||
|
Differential Proteins:
|
||
|
Quantified Proteins:
|
||
| Browse Dataset Files | |
|
FTP Download Link (click to copy):
|